Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

PRNA mutlivalent junction domain for use in stable multivalent RNA nanoparticles

一种纳米颗粒、稳定的技术，应用在DNA / RNA片段、重组DNA技术、微生物的测定/检验等方向，能够解决RNA纳米颗粒不稳定、阻碍RNA纳米颗粒递送效率和治疗应用、离解等问题

Active Publication Date: 2013-11-20
UNIVERSITY OF CINCINNATI
View PDF24 Cites 62 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0016] However, a challenge in this emerging field is the relative instability of RNA nanoparticles formed without covalent modification or chemical cross-linking, leading to their dissociation at ultra-low concentrations in vivo in the human and animal circulatory systems.
This instability severely hampers the delivery efficiency and therapeutic applications of RNA nanoparticles

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • PRNA mutlivalent junction domain for use in stable multivalent RNA nanoparticles
  • PRNA mutlivalent junction domain for use in stable multivalent RNA nanoparticles
  • PRNA mutlivalent junction domain for use in stable multivalent RNA nanoparticles

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0214] experimental method

[0215] In vitro synthesis and purification of pRNA and chemically modified pRNA. pRNA was synthesized by enzymatic methods as described previously. RNA oligonucleotides were chemically synthesized by IDT. 2'-Deoxy-2'-fluoro(2'-F) modified RNA was synthesized by in vitro transcription with mutant Y639F T7 RNA polymerase using 2'-F modified dCTP and dUTP (Trilink).

[0216] Construction and purification of pRNA dimers and trimers. In 5mM magnesium [TBM (89mM Tris, 200mM boric acid, 5mM MgCl 2 , pH7.6) or TMS (89mM Tris, 5mM MgCl 2 , pH 7.6) buffer] in the presence of pRNAAb' and pRNABa' in equimolar ratios were mixed to construct dimers. Similarly, trimers were assembled by mixing pRNAAb', pRNABc' and pRNACa'. To purify the complex, the band corresponding to the trifurcation domain was excised from an 8% non-denaturing PAGE gel and washed at 37°C (0.5M NH 4 OAC, 0.1 mM EDTA, 0.1% SDS and 0.5 mM MgCl 2 ) to 4 hours, followed by ethanol precipi...

example 2

[0265] Construction of trifurcation domain and its derivatives from Phi29pRNA

[0266] Unique properties displayed by trifurcation domains assembled from three RNA oligonucleotides. use a 3WJ , b 3WJ and c 3WJ ( figure 1 D) Three pieces of RNA oligonucleotides representing the construction of the trifurcation domain of phi29pRNA. oligonucleotide a 3WJ , b 3WJ and c 3WJ Two anti-ethidium bromide stains in ( Figure 8 A). Using SYBR Green II RNA gel stain, a 3WJ Can be slightly stained, while c 3WJ is still uncolorable ( Figure 8 A). Ethidium bromide is an intercalating reagent that generally stains dsRNA and dsDNA as well as ssRNA including secondary structure or base stacking. SYBR Green II is known for its ability to stain single- and double-stranded RNA or DNA. especially in c 3WJ In , the absence of staining indicates unique structural properties.

[0267] Three oligonucleotides a 3WJ , b 3WJ and c 3WJ Mixing at room temperature at a stoichiometric rati...

example 3

[0287] Construction of diverse therapeutic RNA nanoparticles using X-motifs as scaffolds

[0288] One advantage of RNA nanotechnology is the feasibility of constructing therapeutic particles with multiple therapeutic agents of defined structure and stoichiometry. However, the controlled assembly of stable RNA nanoparticles with multiple functional molecules to maintain the original role is challenging due to refolding after fusion. In the present invention, we report the construction of thermodynamically stable X-shaped RNA nanoparticles to carry four siRNAs using a redesigned RNA fragment from the central domain of the pRNA of the phage phi29 DNA packaging motor. Tetravalent X-shaped nanoparticles self-assemble very efficiently in the absence of divalent salts, are resistant to denaturation by 8 moles of urea, and remain intact at ultra-low concentrations. We demonstrate that each arm of the four helical strands in the X-motif can contain an siRNA, ribozyme, or aptamer witho...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Trifurcate RNA junction domains derived from phi29 pRNA are described that assemble with high affinity and that are stable in vitro and in vivo. Further expansion of trifurcated RNA domains to multiple way junction scaffolds via creative designs enable an array of toolkit to construct nanoparticle architectures with diverse shapes and angles. The scaffolds can be used to form RNA nanoparticles having a wide variety of uses, including promotion of RNA crystallization, creation of RNA aptamer with high affinity to mimic antibody, delivery of therapeutic and / or diagnostic agents such as biologically active RNA-based moieties, including siRNA, ribozymes, aptamers, and others.

Description

[0001] Statement of Government Interests [0002] This invention was made with US Government support and was made under grants from the National Institutes of Health under Program Grant Nos. GM059944, EB003730, EY018230, and U01CA151648. The United States Government reserves certain rights in this invention. [0003] Priority claims and cross-references [0004] This application claims the benefit of priority to US Provisional Application 61 / 494,706, filed June 8, 2011, under 35 U.S.C. Section 119(e). This provisional application is hereby incorporated into this application in its entirety. Additionally, Shu et al., Nature Nanotechnology, Vol. 6, October 2011, US Patent 7,655,787, US Patent 8,088,912, and PCT / US12 / 020469 are all incorporated herein. technical field [0005] Embodiments of the invention disclosed herein relate to an RNA nanoparticle and methods for preparing the RNA nanoparticle and uses of the RNA nanoparticle. In particular, embodiments of the invention r...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/68C12N15/11
CPCC12N15/111C12N2310/12C12N2310/16C12N2320/31C12N15/1137C12N15/115C12N2330/31C12N2310/51C12N2310/14C12N15/113
Inventor 郭培宣
Owner UNIVERSITY OF CINCINNATI
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com